NPPM
GILD icon

North Point Portfolio Managers’s Gilead Sciences GILD Stock Holding History

North Point Portfolio Managers’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$98.4K Buy
+660
New +$92.6K 0.02% 100
2020
Q1 		– Sell
-155,920
Closed -$10.1M – 68
2019
Q4 		$10.1M Sell
155,920
-2,649
-2% -$173K 1.73% 34
2019
Q3 		$10.1M Sell
158,569
-5,415
-3% -$354K 1.84% 33
2019
Q2 		$11.1M Sell
163,984
-718
-0.4% -$47.2K 2.03% 28
2019
Q1 		$10.7M Buy
164,702
+6,474
+4% +$430K 2.03% 27
2018
Q4 		$9.9M Sell
158,228
-11,609
-7% -$811K 2.19% 22
2018
Q3 		$13.1M Sell
169,837
-3,806
-2% -$287K 2.23% 22
2018
Q2 		$12.3M Sell
173,643
-5,991
-3% -$423K 2.12% 27
2018
Q1 		$13.5M Sell
179,634
-4,523
-2% -$360K 2.32% 24
2017
Q4 		$13.2M Sell
184,157
-18,248
-9% -$1.39M 2.23% 25
2017
Q3 		$16.4M Sell
202,405
-2,480
-1% -$190K 2.77% 11
2017
Q2 		$14.5M Sell
204,885
-1,575
-0.8% -$105K 2.53% 20
2017
Q1 		$14M Sell
206,460
-2,565
-1% -$180K 2.52% 16
2016
Q4 		$15M Sell
209,025
-4,278
-2% -$318K 2.83% 10
2016
Q3 		$16.9M Sell
213,303
-122
-0.1% -$9.91K 3.22% 7
2016
Q2 		$17.8M Sell
213,425
-4,657
-2% -$413K 3.5% 5
2016
Q1 		$20M Sell
218,082
-3,665
-2% -$331K 3.85% 2
2015
Q4 		$22.4M Sell
221,747
-2,980
-1% -$310K 4.33% 1
2015
Q3 		$22.1M Sell
224,727
-1,097
-0.5% -$122K 4.4% 1
2015
Q2 		$26.4M Sell
225,824
-252
-0.1% -$27.5K 4.82% 1
2015
Q1 		$22.2M Buy
226,076
+3,669
+2% +$373K 4.11% 2
2014
Q4 		$21M Buy
222,407
+3,500
+2% +$362K 4% 3
2014
Q3 		$23.3M Sell
218,907
-31,115
-12% -$3.05M 4.67% 1
2014
Q2 		$20.7M Buy
250,022
+1,069
+0.4% +$83.2K 4.17% 1
2014
Q1 		$17.6M Buy
248,953
+3,850
+2% +$302K 3.74% 2
2013
Q4 		$18.4M Buy
245,103
+376
+0.2% +$26.2K 3.92% 1
2013
Q3 		$15.4M Sell
244,727
-2,833
-1% -$169K 3.63% 3
2013
Q2 		$12.7M Buy
+247,560
New +$12.9M 3.19% 6

Other funds holding GILD

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Confluence Investment Management
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
Bailard
Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
CA
CapWealth Advisors Franklin, Tennessee $1.32B AUM 21.6% 1-Year Est. Return

North Point Portfolio Managers's GILD Position: Q3 2026 in Review

North Point Portfolio Managers opened a new position in Gilead Sciences (GILD) in Q3 2026: 660 shares worth $98.4K. The stake represents 0.02% of the portfolio and ranks #100 among its holdings. This is a return to the name: North Point Portfolio Managers previously reported a position in GILD as recently as Q4 2019.

North Point Portfolio Managers first reported a position in GILD in Q2 2013 and has held it in 28 quarters since. The position peaked at $26.4M in Q2 2015. 282 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • North Point Portfolio Managers held 660 shares of Gilead Sciences worth $98.4K as of Q3 2026.
  • Gilead Sciences was a new North Point Portfolio Managers position in Q3 2026.
  • Gilead Sciences made up 0.02% of North Point Portfolio Managers's portfolio in Q3 2026, its #100 holding.
  • North Point Portfolio Managers first reported a position in Gilead Sciences in Q2 2013 and has held it in 28 quarters since.
  • North Point Portfolio Managers's Gilead Sciences position peaked at $26.4M in Q2 2015.
  • 282 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on North Point Portfolio Managers's 13F filing for Q3 2026, filed 7 Oct 2026.